Hemoperfusion in toxic ingestions and hepatic encephalopathy: have the expectations been achieved?
D000327:Adsorption; D001787:Blood Group Incompatibility / Q000209:etiology; D002606:Charcoal / Q000627:therapeutic use; D004617:Embolism / Q000209:etiology; D006464:Hemoperfusion / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D006501:Hepatic Encephalopathy / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D011041:Poisoning / Q000188:drug therapy* / Q000401:mortality; D011137:Polystyrenes / Q000627:therapeutic use; D011145:Polyvinyls / Q000627:therapeutic use
D011137:Polystyrenes; D011145:Polyvinyls; D002606:Charcoal; C012101:XAD-4 resin